Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -70,335 | -50,231 | -30,069 | -89,056 | -56,617 |
| Depreciation Amortization | -2,919 | -1,477 | -506 | -846 | -249 |
| Accounts payable and accrued liabilities | 309 | 1,289 | -6,665 | 10,606 | 5,627 |
| Other Working Capital | -3,747 | 1,152 | 1,037 | 6,747 | -1,789 |
| Other Operating Activity | 9,655 | 5,203 | 9,911 | 4,953 | 6,594 |
| Operating Cash Flow | $-67,037 | $-44,064 | $-26,292 | $-67,596 | $-46,434 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -62 | -62 |
| Purchase Of Investment | -171,730 | -143,058 | -34,209 | -148,490 | -137,927 |
| Sale Of Investment | 113,743 | 68,843 | 46,443 | 78,000 | 54,000 |
| Investing Cash Flow | $-57,987 | $-74,215 | $12,234 | $-70,552 | $-83,989 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 19,816 | N/A |
| Common Stock Issued | 115,969 | 115,672 | 115,240 | 88,214 | 87,388 |
| Other Financing Activity | -7,256 | -7,256 | -7,256 | -6,097 | -6,164 |
| Financing Cash Flow | $108,713 | $108,416 | $107,984 | $101,933 | $81,224 |
| Beginning Cash Position | 43,752 | 43,752 | 43,752 | 79,967 | 79,967 |
| End Cash Position | 27,441 | 33,889 | 137,678 | 43,752 | 30,768 |
| Net Cash Flow | $-16,311 | $-9,863 | $93,926 | $-36,215 | $-49,199 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,037 | -44,064 | -26,292 | -67,596 | -46,434 |
| Capital Expenditure | N/A | N/A | N/A | -62 | -62 |
| Free Cash Flow | -67,037 | -44,064 | -26,292 | -67,658 | -46,496 |